Wells Fargo Maintains Overweight Rating, Raises PT to $135 from $130
ByAinvest
Thursday, Jul 10, 2025 10:05 am ET1min read
BLK--
Wells Fargo's latest rating and price target adjustment come after a period of significant market activity surrounding FRPT. In the past six months, analysts have issued a mix of buy and sell ratings, with a majority favoring the stock. Notably, Wells Fargo's "Overweight" rating aligns with the consensus view among analysts, who have issued an average of 12 price targets in the last six months, with a median target of $115.0 [1].
The bank's insider trading activity also reflects a bullish sentiment. Insiders have made 14 purchases of FRPT stock in the past six months, with no sales reported. This indicates that key insiders are confident in the stock's future prospects [1].
Additionally, hedge funds have shown increased interest in FRPT. Over 197 institutional investors have added shares to their portfolios, while 222 have decreased their positions in the most recent quarter. Notable moves include Blackrock Inc. adding 3.179 million shares to its portfolio in Q1 2025 [1].
Wells Fargo's updated rating and price target for FRPT underscore the bank's confidence in the stock's potential for growth and value appreciation. Investors should closely monitor the bank's performance and any future updates to its rating and price target for FRPT.
References:
[1] https://www.nasdaq.com/articles/new-analyst-forecast-frpt-given-overweight-rating
BPOP--
FRPT--
WFC--
Wells Fargo Maintains Overweight Rating, Raises PT to $135 from $130
In a recent update, Wells Fargo has maintained its "Overweight" rating for First Republic Bancshares Inc. (FRPT) while raising its price target to $135 from $130. This move suggests a positive outlook for the bank's stock performance [1].Wells Fargo's latest rating and price target adjustment come after a period of significant market activity surrounding FRPT. In the past six months, analysts have issued a mix of buy and sell ratings, with a majority favoring the stock. Notably, Wells Fargo's "Overweight" rating aligns with the consensus view among analysts, who have issued an average of 12 price targets in the last six months, with a median target of $115.0 [1].
The bank's insider trading activity also reflects a bullish sentiment. Insiders have made 14 purchases of FRPT stock in the past six months, with no sales reported. This indicates that key insiders are confident in the stock's future prospects [1].
Additionally, hedge funds have shown increased interest in FRPT. Over 197 institutional investors have added shares to their portfolios, while 222 have decreased their positions in the most recent quarter. Notable moves include Blackrock Inc. adding 3.179 million shares to its portfolio in Q1 2025 [1].
Wells Fargo's updated rating and price target for FRPT underscore the bank's confidence in the stock's potential for growth and value appreciation. Investors should closely monitor the bank's performance and any future updates to its rating and price target for FRPT.
References:
[1] https://www.nasdaq.com/articles/new-analyst-forecast-frpt-given-overweight-rating

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet